ZENTALIS PHARMACEUTICALS INC's ticker is ZNTL and the CUSIP is 98943L107. A total of 132 filers reported holding ZENTALIS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.27 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $207 | -45.7% | 10,307 | -23.6% | 0.02% | -46.7% |
| Q2 2023 | $381 | +87.7% | 13,492 | +14.1% | 0.03% | +100.0% |
| Q1 2023 | $203 | -16.1% | 11,821 | -1.6% | 0.02% | -25.0% |
| Q4 2022 | $242 | -99.9% | 12,016 | -4.8% | 0.02% | -23.1% |
| Q3 2022 | $274,000 | -32.0% | 12,628 | -12.0% | 0.03% | -29.7% |
| Q2 2022 | $403,000 | +43.9% | 14,356 | +136.2% | 0.04% | +311.1% |
| Q1 2022 | $280,000 | – | 6,079 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 2,426,095 | $111,940,000 | 6.63% |
| Paradigm Biocapital Advisors LP | 287,577 | $13,269,000 | 3.51% |
| Avidity Partners Management LP | 3,176,999 | $146,587,000 | 3.05% |
| Integral Health Asset Management, LLC | 215,000 | $9,920,000 | 2.58% |
| Matrix Capital Management Company, LP | 4,349,279 | $200,676,000 | 2.41% |
| Affinity Asset Advisors, LLC | 207,500 | $9,574,000 | 1.53% |
| Ikarian Capital, LLC | 202,203 | $9,329,000 | 1.23% |
| Ghost Tree Capital, LLC | 80,000 | $3,691,000 | 0.80% |
| Eventide Asset Management | 761,000 | $35,113,000 | 0.55% |
| Perceptive Advisors | 501,509 | $23,140,000 | 0.46% |